Sivik Global Healthcare’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-40,000
| Closed | -$3.94M | – | 56 |
|
|
2025
Q3 | $3.94M | Buy |
+40,000
| New | +$3.96M | 1.15% | 35 |
|
|
2025
Q1 | – | Sell |
-20,000
| Closed | -$2.11M | – | 45 |
|
|
2024
Q4 | $2.11M | Sell |
20,000
-20,000
| -50% | -$2.15M | 1.11% | 31 |
|
|
2024
Q3 | $4.32M | Buy |
+40,000
| New | +$4.37M | 1.83% | 27 |
|
|
2024
Q1 | – | Sell |
-50,000
| Closed | -$6.08M | – | 55 |
|
|
2023
Q4 | $6.08M | Hold |
50,000
| – | – | 2.54% | 18 |
|
|
2023
Q3 | $5.61M | Sell |
50,000
-5,000
| -9% | -$635K | 2.84% | 18 |
|
|
2023
Q2 | $8.01M | Sell |
55,000
-5,000
| -8% | -$679K | 1.87% | 9 |
|
|
2023
Q1 | $7.75M | Hold |
60,000
| – | – | 3.33% | 9 |
|
|
2022
Q4 | $7.65M | Hold |
60,000
| – | – | 3.6% | 8 |
|
|
2022
Q3 | $6.27M | Buy |
60,000
+10,000
| +20% | +$1.1M | 3.49% | 7 |
|
|
2022
Q2 | $5.25M | Buy |
50,000
+10,000
| +25% | +$1.19M | 2.98% | 14 |
|
|
2022
Q1 | $5.12M | Sell |
40,000
-3,775
| -9% | -$455K | 2.11% | 23 |
|
|
2021
Q4 | $5.4M | Buy |
+43,775
| New | +$5.73M | 2.31% | 22 |
|
|
2021
Q3 | – | Sell |
-61,800
| Closed | -$9.65M | – | 59 |
|
|
2021
Q2 | $9.65M | Sell |
61,800
-5,150
| -8% | -$834K | 1.88% | 10 |
|
|
2021
Q1 | $10.4M | Buy |
66,950
+5,150
| +8% | +$798K | 3.79% | 1 |
|
|
2020
Q4 | $9.24M | Buy |
61,800
+5,150
| +9% | +$727K | 3.77% | 6 |
|
|
2020
Q3 | $7.49M | Buy |
56,650
+30,900
| +120% | +$4.04M | 3.22% | 11 |
|
|
2020
Q2 | $4.36M | Buy |
25,750
+5,150
| +25% | +$593K | 1.44% | 30 |
|
|
2020
Q1 | $2.52M | Sell |
20,600
-15,450
| -43% | -$2.03M | 1% | 36 |
|
|
2019
Q4 | $5.24M | Buy |
+36,050
| New | +$4.98M | 1.94% | 29 |
|
|
2019
Q1 | – | Sell |
-20,600
| Closed | -$2.07M | – | 67 |
|
|
2018
Q4 | $2.07M | Sell |
20,600
-20,600
| -50% | -$2.32M | 1.12% | 38 |
|
|
2018
Q3 | $5.26M | Hold |
41,200
| – | – | 1.88% | 25 |
|
|
2018
Q2 | $4.46M | Buy |
41,200
+22,869
| +125% | +$2.49M | 1.71% | 27 |
|
|
2018
Q1 | $1.94M | Sell |
18,331
-28,019
| -60% | -$3.25M | 0.91% | 47 |
|
|
2017
Q4 | $5.43M | Buy |
46,350
+20,600
| +80% | +$2.33M | 2.02% | 18 |
|
|
2017
Q3 | $2.93M | Buy |
+25,750
| New | +$2.97M | 1% | 38 |
|
|
2017
Q2 | – | Sell |
-41,200
| Closed | -$4.88M | – | 75 |
|
|
2017
Q1 | $4.88M | Buy |
+41,200
| New | +$4.67M | 2.27% | 16 |
|
|
2016
Q4 | – | Sell |
-61,800
| Closed | -$7.8M | – | 64 |
|
|
2016
Q3 | $7.8M | Hold |
61,800
| – | – | 3.93% | 2 |
|
|
2016
Q2 | $7.22M | Buy |
61,800
+10,300
| +20% | +$1.17M | 3.59% | 1 |
|
|
2016
Q1 | $5.33M | Buy |
51,500
+30,900
| +150% | +$2.99M | 2.36% | 15 |
|
|
2015
Q4 | $2.05M | Hold |
20,600
| – | – | 0.97% | 48 |
|
|
2015
Q3 | $1.88M | Sell |
20,600
-20,291
| -50% | -$2.03M | 0.91% | 43 |
|
|
2015
Q2 | $4.34M | Sell |
40,891
-20,909
| -34% | -$2.31M | 1.5% | 27 |
|
|
2015
Q1 | $7.05M | Buy |
61,800
+3,708
| +6% | +$423K | 2.4% | 11 |
|
|
2014
Q4 | $6.4M | Buy |
58,092
+19,982
| +52% | +$2.11M | 2.59% | 8 |
|
|
2014
Q3 | $3.72M | Sell |
38,110
-8,240
| -18% | -$810K | 1.69% | 24 |
|
|
2014
Q2 | $4.67M | Buy |
46,350
+11,021
| +31% | +$1.08M | 2.36% | 14 |
|
|
2014
Q1 | $3.24M | Buy |
35,329
+4,429
| +14% | +$408K | 2.03% | 16 |
|
|
2013
Q4 | $2.8M | Buy |
+30,900
| New | +$2.67M | 1.99% | 24 |
|
Other funds holding ZBH
Sivik Global Healthcare's ZBH Position: Q4 2025 in Review
Sivik Global Healthcare sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 40,000 shares — an estimated $3.94M sold.
Sivik Global Healthcare first reported a position in ZBH in Q4 2013 and held it in 38 quarters. The position peaked at $10.4M in Q1 2021. 945 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.
- Sivik Global Healthcare reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
- Sivik Global Healthcare sold 40,000 Zimmer Biomet shares in Q4 2025, an estimated $3.94M.
- Sivik Global Healthcare first reported a position in Zimmer Biomet in Q4 2013 and held it in 38 quarters.
- Sivik Global Healthcare's Zimmer Biomet position peaked at $10.4M in Q1 2021.
- 945 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.
Based on Sivik Global Healthcare's 13F filing for Q4 2025, filed 21 Jan 2026.